BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective

BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective

V-Raf murine sarcoma viral oncogene homolog B (BRAF) kinase, which was encoded by BRAF gene, plays critical roles in cell signaling, growth, and survival. Mutations in BRAF gene will lead to cancer development and progression. In non-small cell lung cancer (NSCLC), BRAF mutations commonly occur in n...

Full description

Bibliographic Details
Main Authors: Ningning Yan, Sanxing Guo, Huixian Zhang, Ziheng Zhang, Shujing Shen, Xingya Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Oncology
Subjects:
BRAF
NSCLC
targeted therapy
immune checkpoint inhibitors
tyrosine kinase inhibitors
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.863043/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.863043/full

Similar Items